NIFTY 50

Eyeing monetisation via molecules, Suven Neurosciences IPO, says Suven Life Sciences

Updated : January 22, 2020 02:47 PM IST

The company has 13 molecules in the pipeline, out of them, four are in the clinical trials..
Right now the focus is mainly to taking the molecules to the next level.

You May Also Like

Live TV